ConductScience.org, home

Gene · 2852

NIH grants1,925

NIH grants whose papers are about the gene, through NIH's grant-paper links.

161 to 180 of 1,925

Download this page as JSON
GrantTitleGPER1 papersNewest fiscal year
P50CA121974Yale SPORE in Skin Cancer12025
P50CA127001SPORE in Brain Cancer12025
P50CA136393Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer12025
P50DA044118Impact of Cannabinoid Across the Lifespan (ICAL)12025
P50HD103556University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)12025
R01AA011560Ethanol actions on slo channels from arteries vs. brain.12025
R01AA021517Neuromolecular consequences of adolescent binge drinking12025
R01AA026297Aldh2 and epithelial homeostasis and pathobiology12025
R01AG041374Short-term estradiol use in middle-age: implications for female cognitive aging12025
R01AG067419Alzheimer's Disease Pathology in a Primate Model12025
R01AG075583Blood-Brain Barrier Repair in Alzheimer’s Disease with Epilepsy12025
R01AI130110Mechanisms of innate resistance to virus infections12025
R01AI164690RNA:protein interactions that dictate the success of influenza virus infection12025
R01AT011653Functional identification of vagal sensory neurons innervating the liver12025
R01CA072038Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis12025
R01CA121118A High-Throughput Model for Human Melanoma12025
R01CA124515Crosstalk between butyrophilins and gamma delta T cells in human cancer12025
R01CA176839Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy12025
R01CA178441Combinatorial epigenetic-based prevention of breast cancer12025
R01CA197976The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2852/grants?page=9